English
Double masked SYL1001 study in patients with moderate or severe dry eye disease
24/07/2018
RESEARCHER:
Dr. Jesús Merayo Lloves
RECLUTANDO
Double masked SYL1001 study in patients with moderate or severe dry eye disease
INDICATION: Patients with moderate to severe dry eye
TREATMENT: SYL1001
PROMOTOR: SYLENTIS
